Literature DB >> 19706350

"An evil heritage": interview study of pain and autosomal dominant polycystic kidney disease.

Susanne Heiwe1, Monica Bjuke.   

Abstract

Pain is a common problem for patients with autosomal dominant polycystic kidney disease (ADPKD). Knowledge about patients' experience of the pain, pain management, and pain's effect on everyday life is, however, limited. In clinical practice there is a need to improve the care of these patients. To be able to do so, information about how the disease and its pain affect the patients is required. This study explores patients' experience of living with ADPKD and its pain. The findings are based on in-depth semistructured interviews. The participants were 22 patients with ADPKD. The data were transcribed and analyzed by using phenomenology. Findings showed that the patients experienced limitations in their everyday life due to inexplicable and unpredictable pain and fatigue. Also, pain management was experienced as suboptimal and pain was seldom discussed at health care appointments. Emotional distress concerning the hereditary nature of the disease was also present. Health care providers need to increase their focus on pain and pain management to reduce the disease's intrusion in patients' everyday life. Also, patients and people in the patients' immediate surroundings need to be given information and education about the disease and its pain as well as the opportunity to talk about their worries concerning heredity. By implementing the findings of the present study when meeting a patient with ADPKD, improved patient satisfaction and health-related quality of life could be accomplished.

Entities:  

Mesh:

Year:  2009        PMID: 19706350     DOI: 10.1016/j.pmn.2009.03.002

Source DB:  PubMed          Journal:  Pain Manag Nurs        ISSN: 1524-9042            Impact factor:   1.929


  8 in total

Review 1.  Evaluation and management of pain in autosomal dominant polycystic kidney disease.

Authors:  Marie C Hogan; Suzanne M Norby
Journal:  Adv Chronic Kidney Dis       Date:  2010-05       Impact factor: 3.620

2.  The relationship between depression, anxiety, quality of life levels, and the chronic kidney disease stage in the autosomal dominant polycystic kidney disease.

Authors:  Aysenur Miray Yarlioglu; Ebru Gok Oguz; Ayse Gokcen Gundogmus; Kadir Gokhan Atilgan; Hatice Sahin; Mehmet Deniz Ayli
Journal:  Int Urol Nephrol       Date:  2022-10-02       Impact factor: 2.266

Review 3.  Surgical cyst decortication in autosomal dominant polycystic kidney disease.

Authors:  Melissa Millar; Youssef S Tanagho; Mohammed Haseebuddin; Ralph V Clayman; Sam B Bhayani; R Sherburne Figenshau
Journal:  J Endourol       Date:  2013-02-05       Impact factor: 2.942

4.  Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.

Authors:  Dana C Miskulin; Kaleab Z Abebe; Arlene B Chapman; Ronald D Perrone; Theodore I Steinman; Vicente E Torres; K Ty Bae; William Braun; Franz T Winklhofer; Marie C Hogan; Fred Rahbari-Oskoui; Charity G Moore; Michael F Flessner; Robert W Schrier
Journal:  Am J Kidney Dis       Date:  2013-11-01       Impact factor: 8.860

5.  Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment.

Authors:  Christian R Halvorson; Matthew S Bremmer; Stephen C Jacobs
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-06-24

6.  Establishing a core outcome measure for pain in patients with autosomal dominant polycystic kidney disease: a consensus workshop report.

Authors:  Patrizia Natale; Ronald D Perrone; Allison Tong; Tess Harris; Elyssa Hannan; Angela Ju; Eva Burnette; Niek F Casteleijn; Arlene Chapman; Sarah Eastty; Ron T Gansevoort; Marie Hogan; Shigeo Horie; Bertrand Knebelmann; Richard Lee; Reem A Mustafa; Richard Sandford; Amanda Baumgart; Jonathan C Craig; Gopala K Rangan; Bénédicte Sautenet; Andrea K Viecelli; Noa Amir; Nicole Evangelidis; Chandana Guha; Charlotte Logeman; Karine Manera; Andrea Matus Gonzalez; Martin Howell; Giovanni F M Strippoli; Yeoungjee Cho
Journal:  Clin Kidney J       Date:  2021-07-06

7.  Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

Authors:  Tatsuya Suwabe; Yoshifumi Ubara; Koki Mise; Masahiro Kawada; Satoshi Hamanoue; Keiichi Sumida; Noriko Hayami; Junichi Hoshino; Rikako Hiramatsu; Masayuki Yamanouchi; Eiko Hasegawa; Naoki Sawa; Kenmei Takaichi
Journal:  BMC Nephrol       Date:  2013-08-27       Impact factor: 2.388

8.  Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physicians.

Authors:  Anna Baker; Dominic King; James Marsh; Andrew Makin; Alison Carr; Catherine Davis; Cara Kirby
Journal:  Clin Kidney J       Date:  2015-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.